75 results
40-F
2021 FY
EX-99.1
BLU
Bellus Health Inc
23 Feb 22
Annual report (Canada)
5:20pm
of pharmaceutical products conducted by others may cause the FDA or other regulatory oversight bodies to suspend or terminate our clinical trials, to change … to continuing oversight by governmental Health Authorities and institutional review boards or ethics committees, and must meet the requirements
40-F
2007 FY
EX-99.2
BLU
Bellus Health Inc
14 Mar 08
Annual report (Canada)
12:00am
, we also conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require … of the Public Company Accounting Oversight Board (United States), the Company’s internal control over financial reporting as of December 31, 2007, based
40-F/A
2007 FY
EX-99.1
BLU
Bellus Health Inc
27 Mar 07
Annual report (Canada) (amended)
12:00am
product candidates.
Clinical trials are subject to continuing oversight by governmental regulatory authorities and institutional review boards … Rovinescu.
Audit Committee
The mandate of the Audit Committee includes assisting the Board in its oversight of (i) the integrity of the Corporation’s
F-10
EX-4.1
BLU
Bellus Health Inc
3 Sep 19
Registration of securities (Canada)
7:53am
the required regulatory approvals to commercialize that drug candidate.
Clinical trials are subject to continuing oversight by governmental regulatory … in its oversight of (i) the integrity of the Company’s financial statements, accounting and financial reporting processes, system of internal
F-10
EX-4.1
BLU
Bellus Health Inc
20 Dec 19
Registration of securities (Canada)
4:03pm
the required regulatory approvals to commercialize that drug candidate.
Clinical trials are subject to continuing oversight by governmental regulatory … in its oversight of (i) the integrity of the Company’s financial statements, accounting and financial reporting processes, system of internal
40-F
EX-1
58qb9xtbctcjwwr im
22 Mar 06
Annual report (Canada)
12:00am
40-F
EX-99.1
93lgmc1qrorav53cwv
27 Feb 20
Annual report (Canada)
5:13pm
6-K
EX-99.3
xzsjb3 opg
26 Mar 09
Current report (foreign)
12:00am
40-F
EX-99.1
ykm r6jf8c
14 Mar 08
Annual report (Canada)
12:00am
40-F
EX-99.1
ygd hj5kjw
25 Feb 21
Annual report (Canada)
4:58pm
6-K
hx05lyduc1a2iri
14 Mar 08
Current report (foreign)
12:00am
6-K
EX-99.2
3ifvnn30k
26 Mar 09
Current report (foreign)
12:00am
SUPPL
dgtmdqapw0xret5wm
14 Nov 22
Supplemental materials (foreign)
5:25pm
40-F
EX-99.3
kkm64gthba
23 Feb 22
Annual report (Canada)
5:20pm
F-10
EX-4.4
2wy7sycj7r4p5fis n1
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
EX-4.4
jdoz9r h10
3 Sep 19
Registration of securities (Canada)
7:53am
6-K
EX-99.1
6n3jh75by89fg
29 Mar 23
Current report (foreign)
5:26pm
F-10
gcxxdte4
26 Aug 22
Registration of securities (Canada)
4:48pm
F-10/A
qe11z7h5m0u1
17 Jan 20
Registration of securities (Canada) (amended)
4:21pm
6-K
EX-99.1
cqde351 rren
5 Apr 22
Current report (foreign)
4:07pm